Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Marseille
Clinical trial register · France

Clinical Trials in Marseille, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9697 matching records held by the registry are in this view. Synced 26 Oct 2026, 03:20 UTC
9697
Studies in scope
all four open statuses
6025
Recruiting now
open to new participants
1033
Lead sponsors
across recruiting studies
Top sites
Paris 31 Lille 23 Nantes 17 Toulouse 15 Marseille 15
Narrow the registerReset
Recruitment status
Phase
Site location
Paris31 Lille23 Nantes17 Toulouse15 Marseille15
All 73 locations
Target enrolment
to

Trials with a site in Marseille

15 of 9697 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Recruiting
Sanofi
Phase 3
751
Amiens, Besançon, Créteil, La Tronche, Lille, Marseille, Nantes, Nice
2026-01-16
Recruiting
Sanofi
Phase 2
37
Marseille, Paris
2025-12-02
Recruiting
Sanofi
Phase 3
980
Amiens, Saint-Etienne, Besançon, Créteil, La Tronche, Lille, Marseille, Nantes
2025-10-01
Recruiting
Sanofi
Phase 3
124
Clichy, Dijon, Lille, Lyon, Marseille, Pessac, Suresnes
2025-09-26
Recruiting
Sanofi
Phase 4
218
La Tronche, Lille, Lyon, Marseille, Montpellier, Pessac, Reims
2025-09-22
Recruiting
Sanofi
Phase 3
192
Créteil, Marseille, Paris, Toulouse
2025-08-12
By invitation
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
NCT06859099Polyneuropathy, Inflammatory Demyelinating, Chronic
Sanofi
Phase 3
300
Bordeaux, Le Kremlin-Bicêtre, Marseille, Montpellier, Nice, Paris
2025-04-01
Active, closed
Sanofi
Phase 3
216
Bordeaux, Marseille, Nantes, Poitiers, Pontoise, Toulouse
2025-02-06
Recruiting
Sanofi
Phase 3
160
Le Kremlin-Bicêtre, Lille, Marseille, Nice, Paris
2024-08-21
Active, closed
A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work
NCT06290128Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Polyneuropathy, Inflammatory Demyelinating, Chronic
Sanofi
Phase 3
109
Le Kremlin-Bicêtre, Lille, Marseille, Montpellier, Paris
2024-07-12
Active, closed
Sanofi
Phase 3
260
Marseille, Nantes, Paris, Pessac, Pierre-Bénite, Rennes, Vandœuvre-lès-Nancy
2024-01-23
Recruiting
Sanofi
Phase 3
180
Le Plessis-Robinson, Marseille, Paris, Pessac, Saint-Herblain, Strasbourg, Suresnes
2023-10-10
Active, closed
Sanofi
Phase 2
999
Créteil, Lille, Marseille, Nantes, Paris, Pierre-Bénite, Toulouse
2023-04-03
Active, closed
Sanofi
Phase 2
187
Marseille, Nantes, Neuilly-sur-Seine, Vandœuvre-lès-Nancy
2022-11-25
Active, closed
Sanofi
Observational
1,860
Argenteuil, Bordeaux, Lille, Marseille, Martigues, Nantes, Paris, Toulouse
2019-08-15
Rows per page Showing 1–15 of 15
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 October 2026. https://priyalifescience.com/clinical-trials-france/city/marseille

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,697 studies in total at the last sync on 26 Oct 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 15 of those studies with a site in Marseille that also match the filters currently applied.

How many clinical trials are recruiting in Marseille?

8 of the 15 studies on this page are recruiting new participants as of the 26 Oct 2026, 03:20 UTC sync. A further 0 have not yet opened recruitment, 6 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Marseille), 15 studies
PhaseStudiesRecruitingShare
Phase 310666.7%
Phase 23120%
Observational106.7%
Phase 4116.7%

Most active sponsors

Lead sponsors with the most studies (Marseille)
Lead sponsorStudiesRecruiting
Sanofi158
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.